Search research articles
Contact Us
Filters
Showing results (281-290 of 288) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 288 results.
Nature Medicine
|
June 1, 2026
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Lauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Cancer Discovery
|
August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
Lars D Engstrom, Ruth Aranda, Laura Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Timothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cancer Discovery
|
October 30, 2019
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin, Lars D Engstrom, Lauren Hargis, et al.
The New England Journal of Medicine
|
June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Scientific Data
|
January 9, 2024
Seawater physics and chemistry along the Med-SHIP transects in the Mediterranean Sea in 2016
Katrin Schroeder, Vedrana Kovačević, Giuseppe Civitarese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 288) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 288 results.
Nature Medicine
|
June 1, 2026
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Lauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, et al.
Cancer Discovery
|
August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
Lars D Engstrom, Ruth Aranda, Laura Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Timothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cancer Discovery
|
October 30, 2019
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin, Lars D Engstrom, Lauren Hargis, et al.
The New England Journal of Medicine
|
June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Scientific Data
|
January 9, 2024
Seawater physics and chemistry along the Med-SHIP transects in the Mediterranean Sea in 2016
Katrin Schroeder, Vedrana Kovačević, Giuseppe Civitarese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Page
of 29